000			01589 a2200409 4500
005			20250516220051.0
264		0	_c20140730
008			201407s 0 0 eng d
022			_a1879-355X
024	7		_a10.1016/j.ijrobp.2014.03.039 _2doi
040			_aNLM _beng _cNLM
100	1		_aScharpfenecker, Marion
245	0	0	_aThalidomide ameliorates inflammation and vascular injury but aggravates tubular damage in the irradiated mouse kidney. _h[electronic resource]
260			_bInternational journal of radiation oncology, biology, physics _cJul 2014
300			_a599-606 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAngiogenesis Modulating Agents _xadverse effects
650	0	4	_aAnimals
650	0	4	_aAnti-Inflammatory Agents _xadverse effects
650	0	4	_aFemale
650	0	4	_aFibrosis
650	0	4	_aGenes, sis _xdrug effects
650	0	4	_aGlomerular Filtration Rate _xdrug effects
650	0	4	_aKidney _xblood supply
650	0	4	_aKidney Tubules _xdrug effects
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aNephritis _xpathology
650	0	4	_aRadiation Injuries, Experimental _xprevention & control
650	0	4	_aThalidomide _xadverse effects
700	1		_aFloot, Ben
700	1		_aRussell, Nicola S
700	1		_aCoppes, Rob P
700	1		_aStewart, Fiona A
773	0		_tInternational journal of radiation oncology, biology, physics _gvol. 89 _gno. 3 _gp. 599-606
856	4	0	_uhttps://doi.org/10.1016/j.ijrobp.2014.03.039 _zAvailable from publisher's website
999			_c23918568 _d23918568